A prospective study on the development of alzheimer's disease with regard to thyroid-stimulating hormone and homocysteine

Dementia and Geriatric Cognitive Disorders

Volumn 28, Issue 3, 2009, Pages 275-280

  Annerbo, Sylvia ^a   Kivipelto, Miia ^a   Lökk, Johan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Alzheimer's disease; Dementia; Homocysteine; Thyroid stimulating hormone

Indexed keywords

HOMOCYSTEINE; THYROTROPIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; RISK FACTOR;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; COHORT STUDIES; CREATININE; DISEASE PROGRESSION; FEMALE; HOMOCYSTEINE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SOCIOECONOMIC FACTORS; SWEDEN; THYROTROPIN;

EID: 70349585289     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000242439     Document Type: Article

References (43)

1. De Jong FJ, den Heijer T, Visser TJ, de Rijke YB, Drexhage HA, Hofman A, Breteler MMB: Thyroid hormones, dementia, and atrophy of the medial temporal lobe. J Clin Endocrinol Metab 2006: 2569-2573.
2. Lopez O, Huff FJ, Martinez AJ, Bedetti CD: Prevalence of thyroid abnormalities is not increased in Alzheimer's disease. Neurobiol Aging 1989; 10: 247-251.
3. Yoshimasu F, Kokmen E, Hay ID, Beard CM, Offord KP, Kurland LT: The association between Alzheimer's disease and thyroid disease in Rochester, Minnesota. Neurology 1991; 41: 1745-1747.
4. Breteler MM, van Duijn CM, Chandra V, Fratiglioni L, Graves AB, Heyman A, et al, Eurodem Risk Factors Research Group: Medical history and the risk of Alzheimer's disease: a collaborative re-analysis of casecontrol studies. Int J Epidemiol. 1991; 20 (suppl 2):S36-S42.
5. Ganguli M, Burmeister LA, Seaberg EC, Belle S, DeKosky S: Association between dementia and elevated TSH: a communitybased study. Biol Psychiatry 1996; 40: 714-725.
6. Krysiak R, Marek B, Okopien: Subclinical hyperthyroidism. Endokrynol Pol 2007; 58: 536-542.
7. Volpato S, Guralnik JM, Fried LP, Remaley AT, Cappola AR, Launer L: Serum thyroxin level and cognitive decline in euthyroid older women. Neurology 2002; 58: 1055-1061.
8. Luo L, Yano N, Mao Q, Jackson IM, Stopa EG: Thyrotrophic releasing hormone (TRH) in the hippocampus of Alzheimer patients. J Alzheimers Dis 2002; 4: 97-103.
9. Van Osch LA, Hogervorst E, Combrinck M, Smith AD: Low thyroid-stimulating hormone as an independent risk factor for Alzheimer disease. Neurology 2004; 62: 1967-1971. (Pubitemid 38738205)
10. Annerbo S, Wahlund L-O, Lökk J: The significance of thyroid-stimulating hormone and homocysteine in the development of Alzheimer's disease in mild cognitive impairment. Am J Alzheimer Dis Other Demen 2006; 3: 182-188.
11. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC: Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study. Ann Intern Med 2000; 132: 270-278.
12. Biondi B, Palmieri EA, Lombardi G, Fazio S: Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med 2002; 137: 904-914.
13. Morris MS, Bostom AG, Jacques PF, Selhub J, Rosenberg IH: Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the Third US National Health and Nutrition Examination Survey. Atherosclerosis 2001; 155: 195-200. (Pubitemid 32167140)
14. Kivipelto M, Helkala E-L, Laakso MP, Hänninen T, Hallikainen M, Alhainen K, et al: Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population- based study. BMJ 2001; 332: 1447-1451.
15. Hogervorst E, Huppert F, Matthews FE, Brayne C: Thyroid function and cognitive decline in the MRC Cognitive Function and Ageing Study. Psychoneuroendocrinology 2008; 33: 1013-1027.
16. Mafrica F, Fodale V: Thyroid function, Alzheimer's disease and postoperative cognitive decline: a tale of dangerous liaisons? J Alzheimer Dis 2008; 14: 95-105.
17. Kelly GS: Peripheral metabolism of thyroid hormones: a review. Altern Med Rev 2000; 5: 306-333.
18. Oldreive CE, Doherty GH: Neurotoxic effects of homocysteine on cerebellar Purkinje neurons in vitro. Neurosci Lett 2007; 413: 52-57.
19. Kalmijn S, Metha KM, Pols HAP, Hofman A, Drexhage HA, Breteler MMB: Subclinical hyperthyroidism and the risk of dementia: The Rotterdam Study. Clin Endocrinol 2000; 53: 733-737. (Pubitemid 32096685)
20. Wang HX, Wahlin Å, Basun H, Fastborn J, Winblad B, Fratiglioni L: Vitamin B 12 and folate in relation to the development of Alzheimer's disease. Neurology 2001; 56: 1188-1194. (Pubitemid 32405713)
21. Basun H, Fratiglioni L, Winblad B: Cobalamin levels are not reduced in Alzheimer's disease: results from a population-based study. J Am Geriatr Soc 1994; 42: 132-136.
22. Quadri P, Fragiacomo C, Pezzati R, et al: Homocysteine, folate, and vitamin B 12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am J Clin Nutr 2004; 80: 114-122.
23. McIlroy SP, Dynan KB, Lawson JT, Patterson CC, Passmore AP: Moderately elevated plasma homocysteine, methylentetrahydrofolate reductase genotype, and risk for stroke, vascular dementia and Alzheimer's disease in Northern Ireland. Stroke 2002; 33: 2351-2356.
24. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM: Folate, vitamin B 12 , and serum total homocysteine levels in confirmed Alzheimer's disease. Arch Neurol 1998; 55: 1449-1455.
25. McCaddon A, Davis G, Hudson P, Tandy S, Cattell H: Total serum homocysteine in senile dementia of Alzheimer type. Int J Geriatr Psychiatry 1998; 13: 235-239.
26. Mizrahi EH, Bowirrat A, Jacobsen DW, Korczyn AD, Traore F, Petot GJ, et al: Plasma homocysteine, vitamin B 12 and folate in Alzheimer's patients and healthy Arabs. J Neurol Sci 2004; 227: 109-113.
27. Luchsinger JA, Tang MX, Shea S, Miller J, Green R, Mayeux R: Plasma homocysteine levels and risk of Alzheimer disease. Neurology 2004; 62: 1972-1976. (Pubitemid 38738206)
28. Miller JW, Green R, Mungas DM, Reed BR, Jagust WJ: Homocysteine, vitamin B 6 , and vascular disease in AD patients. Neurology 2002; 58: 1471-1475.
29. Annerbo S, Wahlund L-O, Lökk J: The relation between homocysteine levels and development of Alzheimer's disease in mild cognitive impairment patients. Dement Geriatr Cogn Disord 2005; 20: 209-214.
30. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, et al: Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002; 346: 476-483. (Pubitemid 34441738)
31. Haan MN, Miller JW, Aiello AE, Whitmer RA, Jagust WJ, Mungas DM et al: Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment; results from the Sacramento Area Latino Study on Aging. Am J Clin Nutr 2007; 85: 511-517.
32. Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunetti N, et al: Homocysteine and folate as risk factors for dementia and Alzheimer's disease. Am J Clin Nutr 2005; 82: 636-643.
33. Fratiglioni L, Viitanen M, Bäckman L, Sandman PO, Winblad B: Occurrence of dementia in advanced age: the study design of the Kungsholmen Project. Neuroepidemiology 1992; 11(suppl 1):29-36.
34. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R), ed 3, rev. Washington, American Psychiatric Association, 1987, pp 97-163.
35. Sala I, Belén Sanches-Saudinós M, Molina- Porcel L, Lazaro E, Gich I, Clarimon J, et al: Homocysteine and cognitive impairment: relation with diagnosis and neuropsychological performance. Dement Geriatr Cogn Disord 2008; 26: 506-512.
36. Luchsinger JA, Tang MX, Miller J, Green R, Mayeux R: Relation of higher folate intake to lower risk of Alzheimer disease in the elderly. Arch Neurol 2007: 64: 86-92.
37. Wahlin Å, Hill RD, Winblad B, Bäckman L: Effects of serum vitamin B 12 and folate status on episodic memory performance in very old age: a population-based study. Psychol Aging 1996; 11: 487-496.
38. Nilsson K, Gustafson L, Hultberg B: Improvement of cognitive functions after cobalamin/ folate supplementation in elderly patients with dementia and elevated plasma homocysteine. Int J Geriatr Psychiatry 2001; 16: 609-614.
39. Aisen PS, Schneider LS, Sano M, Diaz-Arrastia R, van Dyck CH, Weiner M, et al: High-dose B-vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. JAMA 2008; 300: 1774-1783.
40. Wiener R, Utiger RD, Lew R, Emerson CH: Age, sex, and serum thyrotropin concentrations in primary hypothyroidism. Acta Endocrinol (Copenh) 1991; 124: 364-369.
41. Sawin CT: Age-related changes in thyroid function; in Braverman LE, Utiger RD (eds): Werner & Ingbar's The Thyroid: A Fundamental and Clinical Text, ed 8. Philadelphia, Lippincott Williams & Wilkins, 2000, pp 254-256.
42. Stuerenburg HJ, Arit S, Mueller-Thomsen T: Free thyroxine, cognitive decline and depression in Alzheimer's disease. Neuroendocrinol Lett 2006; 27: 535-537.
43. Thomas DR, Hailwood R, Harris B, Williams PA, Scanion MF, Johan R: Thyroid status in senile dementia of the Alzheimer type (SDAT). Acta Psychiatr Scand 1987; 76: 158-163.